APO Research
Talk to an analyst

APO RESEARCH · REPORT

Open-Angle Glaucoma Therapeutics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Open-Angle Glaucoma Therapeutics Industry Growth and Trends Forecast to 2032

22 December 202585 pages

Choose your research edition.

Industry ResearchOpen-Angle Glaucoma Therapeutics Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Open-Angle Glaucoma Therapeutics Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Open-Angle Glaucoma Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Open-Angle Glaucoma Therapeutics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Open-Angle Glaucoma Therapeutics Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

According to APO Research, the global Open-Angle Glaucoma Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Open-Angle Glaucoma Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Open-Angle Glaucoma Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Open-Angle Glaucoma Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Open-Angle Glaucoma Therapeutics market include Novartis AG, Pfizer Inc., Bausch Health Companies, Inc., Allergan Plc and Aerie Pharmaceuticals Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Open-Angle Glaucoma Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Open-Angle Glaucoma Therapeutics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Open-Angle Glaucoma Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Open-Angle Glaucoma Therapeutics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Open-Angle Glaucoma Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Open-Angle Glaucoma Therapeutics Market by Company

Novartis AG

Pfizer Inc.

Bausch Health Companies, Inc.

Allergan Plc

Aerie Pharmaceuticals Inc.

Open-Angle Glaucoma Therapeutics Segment by Type

Prostaglandin Analogs (PGAs)

Combination of PGAs

Other

Open-Angle Glaucoma Therapeutics Segment by Application

Clinic

Hospital

Research Institute

Other

Open-Angle Glaucoma Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Open-Angle Glaucoma Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Open-Angle Glaucoma Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Open-Angle Glaucoma Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Open-Angle Glaucoma Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Open-Angle Glaucoma Therapeutics Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Open-Angle Glaucoma Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Open-Angle Glaucoma Therapeutics Market Share by Region (2021-2026) Table 4. Global Open-Angle Glaucoma Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Open-Angle Glaucoma Therapeutics Market Share by Region (2027-2032) Table 6. Global Open-Angle Glaucoma Therapeutics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Open-Angle Glaucoma Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Open-Angle Glaucoma Therapeutics Market Size Share by Type (2021-2026) Table 9. Global Open-Angle Glaucoma Therapeutics Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Open-Angle Glaucoma Therapeutics Market Size Share Forecasted by Type (2027-2032) Table 11. North America Open-Angle Glaucoma Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Open-Angle Glaucoma Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Open-Angle Glaucoma Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Open-Angle Glaucoma Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Open-Angle Glaucoma Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Open-Angle Glaucoma Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Open-Angle Glaucoma Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Open-Angle Glaucoma Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Open-Angle Glaucoma Therapeutics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Open-Angle Glaucoma Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Open-Angle Glaucoma Therapeutics Market Size Share by Application (2021-2026) Table 24. Global Open-Angle Glaucoma Therapeutics Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Open-Angle Glaucoma Therapeutics Market Size Share Forecasted by Application (2027-2032) Table 26. North America Open-Angle Glaucoma Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Open-Angle Glaucoma Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Open-Angle Glaucoma Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Open-Angle Glaucoma Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Open-Angle Glaucoma Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Open-Angle Glaucoma Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Open-Angle Glaucoma Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Open-Angle Glaucoma Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Open-Angle Glaucoma Therapeutics Industry Trends Table 37. Open-Angle Glaucoma Therapeutics Industry Drivers Table 38. Open-Angle Glaucoma Therapeutics Industry Opportunities and Challenges Table 39. Open-Angle Glaucoma Therapeutics Industry Restraints Table 40. Global Open-Angle Glaucoma Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Company (2021-2026) Table 42. Global Open-Angle Glaucoma Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Open-Angle Glaucoma Therapeutics Key Company Headquarters & Area Served Table 44. Global Open-Angle Glaucoma Therapeutics Company, Product Type & Application Table 45. Global Open-Angle Glaucoma Therapeutics Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Open-Angle Glaucoma Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Novartis AG Company Information Table 49. Novartis AG Business Overview Table 50. Novartis AG Open-Angle Glaucoma Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Novartis AG Open-Angle Glaucoma Therapeutics Product Portfolio Table 52. Novartis AG Recent Development Table 53. Pfizer Inc. Company Information Table 54. Pfizer Inc. Business Overview Table 55. Pfizer Inc. Open-Angle Glaucoma Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Pfizer Inc. Open-Angle Glaucoma Therapeutics Product Portfolio Table 57. Pfizer Inc. Recent Development Table 58. Bausch Health Companies, Inc. Company Information Table 59. Bausch Health Companies, Inc. Business Overview Table 60. Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Product Portfolio Table 62. Bausch Health Companies, Inc. Recent Development Table 63. Allergan Plc Company Information Table 64. Allergan Plc Business Overview Table 65. Allergan Plc Open-Angle Glaucoma Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Allergan Plc Open-Angle Glaucoma Therapeutics Product Portfolio Table 67. Allergan Plc Recent Development Table 68. Aerie Pharmaceuticals Inc. Company Information Table 69. Aerie Pharmaceuticals Inc. Business Overview Table 70. Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Product Portfolio Table 72. Aerie Pharmaceuticals Inc. Recent Development Table 73. North America Open-Angle Glaucoma Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 74. North America Open-Angle Glaucoma Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 75. North America Open-Angle Glaucoma Therapeutics Market Share by Country (2021-2026) Table 76. North America Open-Angle Glaucoma Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 77. North America Open-Angle Glaucoma Therapeutics Market Share Forecast by Country (2027-2032) Table 78. Europe Open-Angle Glaucoma Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 79. Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 80. Europe Open-Angle Glaucoma Therapeutics Market Share by Country (2021-2026) Table 81. Europe Open-Angle Glaucoma Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 82. Europe Open-Angle Glaucoma Therapeutics Market Share Forecast by Country (2027-2032) Table 83. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 84. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 85. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Share by Country (2021-2026) Table 86. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 87. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Share Forecast by Country (2027-2032) Table 88. Latin America Open-Angle Glaucoma Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. Latin America Open-Angle Glaucoma Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 90. Latin America Open-Angle Glaucoma Therapeutics Market Share by Country (2021-2026) Table 91. Latin America Open-Angle Glaucoma Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. Latin America Open-Angle Glaucoma Therapeutics Market Share Forecast by Country (2027-2032) Table 93. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 95. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Share by Country (2021-2026) Table 96. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Share Forecast by Country (2027-2032) Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Open-Angle Glaucoma Therapeutics Product Image Figure 3. Global Open-Angle Glaucoma Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Open-Angle Glaucoma Therapeutics Market Size (2021-2032) & (US$ Million) Figure 5. Global Open-Angle Glaucoma Therapeutics Market Share by Region: 2025 VS 2032 Figure 6. Global Open-Angle Glaucoma Therapeutics Market Share by Region (2021-2032) Figure 7. North America Open-Angle Glaucoma Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Open-Angle Glaucoma Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Open-Angle Glaucoma Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Prostaglandin Analogs (PGAs) Image Figure 13. Global Prostaglandin Analogs (PGAs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Combination of PGAs Image Figure 15. Global Combination of PGAs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Other Image Figure 17. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Open-Angle Glaucoma Therapeutics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Open-Angle Glaucoma Therapeutics Market Share by Type 2025 VS 2032 Figure 20. North America Open-Angle Glaucoma Therapeutics Market Size Share by Type (2021-2032) Figure 21. Europe Open-Angle Glaucoma Therapeutics Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size Share by Type (2021-2032) Figure 23. Latin America Open-Angle Glaucoma Therapeutics Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Open-Angle Glaucoma Therapeutics Market Size Share by Type (2021-2032) Figure 25. Clinic Image Figure 26. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Hospital Image Figure 28. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Research Institute Image Figure 30. Global Research Institute Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Other Image Figure 32. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Open-Angle Glaucoma Therapeutics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Open-Angle Glaucoma Therapeutics Market Share by Application 2025 VS 2032 Figure 35. North America Open-Angle Glaucoma Therapeutics Market Size Share by Application (2021-2032) Figure 36. Europe Open-Angle Glaucoma Therapeutics Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size Share by Application (2021-2032) Figure 38. Latin America Open-Angle Glaucoma Therapeutics Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Open-Angle Glaucoma Therapeutics Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Open-Angle Glaucoma Therapeutics Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Open-Angle Glaucoma Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Open-Angle Glaucoma Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Open-Angle Glaucoma Therapeutics Market Share by Country (2021-2032) Figure 45. Europe Open-Angle Glaucoma Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Open-Angle Glaucoma Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Open-Angle Glaucoma Therapeutics Market Share by Country (2021-2032) Figure 48. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Open-Angle Glaucoma Therapeutics Market Share by Country (2021-2032) Figure 51. Latin America Open-Angle Glaucoma Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Open-Angle Glaucoma Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Open-Angle Glaucoma Therapeutics Market Share by Country (2021-2032) Figure 54. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Open-Angle Glaucoma Therapeutics Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Prostaglandin Analogs (PGAs)
  • Combination of PGAs
  • Other
Applications
  • Clinic
  • Hospital
  • Research Institute
  • Other
Companies covered
  • Novartis AG
  • Pfizer Inc.
  • Bausch Health Companies, Inc.
  • Allergan Plc
  • Aerie Pharmaceuticals Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Open-Angle Glaucoma Therapeutics Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Open-Angle Glaucoma Therapeutics Market Size by Region (2021-2032)
  5. 1.4.1 Global Open-Angle Glaucoma Therapeutics Market Size by Region (2021-2026)
  6. 1.4.2 Global Open-Angle Glaucoma Therapeutics Market Size by Region (2027-2032)
  7. 1.5 Key Regions Open-Angle Glaucoma Therapeutics Market Size (2021-2032)
  8. 1.5.1 North America Open-Angle Glaucoma Therapeutics Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Open-Angle Glaucoma Therapeutics Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Open-Angle Glaucoma Therapeutics Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size Growth Rate (2021-2032)
2 Open-Angle Glaucoma Therapeutics Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Prostaglandin Analogs (PGAs)
  3. 2.1.2 Combination of PGAs
  4. 2.1.3 Other
  5. 2.2 Global Open-Angle Glaucoma Therapeutics Market Size by Type
  6. 2.2.1 Global Open-Angle Glaucoma Therapeutics Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Open-Angle Glaucoma Therapeutics Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Open-Angle Glaucoma Therapeutics Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Open-Angle Glaucoma Therapeutics Market Size by Regions
  10. 2.3.1 North America Open-Angle Glaucoma Therapeutics Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Open-Angle Glaucoma Therapeutics Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Open-Angle Glaucoma Therapeutics Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Open-Angle Glaucoma Therapeutics Market Size Breakdown by Type (2021-2026)
3 Open-Angle Glaucoma Therapeutics Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Clinic
  3. 3.1.2 Hospital
  4. 3.1.3 Research Institute
  5. 3.1.4 Other
  6. 3.2 Global Open-Angle Glaucoma Therapeutics Market Size by Application
  7. 3.2.1 Global Open-Angle Glaucoma Therapeutics Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Open-Angle Glaucoma Therapeutics Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Open-Angle Glaucoma Therapeutics Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Open-Angle Glaucoma Therapeutics Market Size by Regions
  11. 3.3.1 North America Open-Angle Glaucoma Therapeutics Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Open-Angle Glaucoma Therapeutics Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Open-Angle Glaucoma Therapeutics Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Open-Angle Glaucoma Therapeutics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Open-Angle Glaucoma Therapeutics Industry Trends
  2. 4.2 Open-Angle Glaucoma Therapeutics Industry Drivers
  3. 4.3 Open-Angle Glaucoma Therapeutics Industry Opportunities and Challenges
  4. 4.4 Open-Angle Glaucoma Therapeutics Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Open-Angle Glaucoma Therapeutics Revenue (2021-2026)
  2. 5.2 Global Open-Angle Glaucoma Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Open-Angle Glaucoma Therapeutics Key Company Headquarters & Area Served
  4. 5.4 Global Open-Angle Glaucoma Therapeutics Company, Product Type & Application
  5. 5.5 Global Open-Angle Glaucoma Therapeutics Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Open-Angle Glaucoma Therapeutics Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Open-Angle Glaucoma Therapeutics Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Open-Angle Glaucoma Therapeutics Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Open-Angle Glaucoma Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Open-Angle Glaucoma Therapeutics Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Pfizer Inc.
  8. 6.2.1 Pfizer Inc. Company Information
  9. 6.2.2 Pfizer Inc. Business Overview
  10. 6.2.3 Pfizer Inc. Open-Angle Glaucoma Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Inc. Open-Angle Glaucoma Therapeutics Product Portfolio
  12. 6.2.5 Pfizer Inc. Recent Developments
  13. 6.3 Bausch Health Companies, Inc.
  14. 6.3.1 Bausch Health Companies, Inc. Company Information
  15. 6.3.2 Bausch Health Companies, Inc. Business Overview
  16. 6.3.3 Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Product Portfolio
  18. 6.3.5 Bausch Health Companies, Inc. Recent Developments
  19. 6.4 Allergan Plc
  20. 6.4.1 Allergan Plc Company Information
  21. 6.4.2 Allergan Plc Business Overview
  22. 6.4.3 Allergan Plc Open-Angle Glaucoma Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Allergan Plc Open-Angle Glaucoma Therapeutics Product Portfolio
  24. 6.4.5 Allergan Plc Recent Developments
  25. 6.5 Aerie Pharmaceuticals Inc.
  26. 6.5.1 Aerie Pharmaceuticals Inc. Company Information
  27. 6.5.2 Aerie Pharmaceuticals Inc. Business Overview
  28. 6.5.3 Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Product Portfolio
  30. 6.5.5 Aerie Pharmaceuticals Inc. Recent Developments
7 North America
  1. 7.1 North America Open-Angle Glaucoma Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Open-Angle Glaucoma Therapeutics Market Size by Country (2021-2026)
  3. 7.3 North America Open-Angle Glaucoma Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Open-Angle Glaucoma Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2021-2026)
  3. 8.3 Europe Open-Angle Glaucoma Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Open-Angle Glaucoma Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Open-Angle Glaucoma Therapeutics Market Size by Country (2021-2026)
  3. 10.3 South America Open-Angle Glaucoma Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst